Arf6, RalA, and BIRC5 protein expression in nonsmall cell lung cancer

Author： Knizhnik A.   Kovaleva O.   Laktionov K.   Mochalnikova V.   Komelkov A.   Tchevkina E.   Zborovskaya I.  

Publisher： MAIK Nauka/Interperiodica

ISSN： 0026-8933

Source： Molecular Biology, Vol.45, Iss.2, 2011-04, pp. : 275-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Study of circulating IgG antibodies to BIRC5 and MYC in non‐small cell lung cancer

By  

FEBS Open Bio, Vol. 5, Iss. 1, 2015-01 ,pp. : 809-812

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O   Hanna Nasser  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

By Bayliss Trevor J   Smith Jeff T   Schuster Michael   Dragnev Konstantin H   Rigas James R  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 12, 2011-12 ,pp. : 1663-1668

Informa Healthcare

Access to resources Recommend Favorite

Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer

By Fu Le  

Biomarkers, Vol. 18, Iss. 2, 2013-03 ,pp. : 126-135

Informa Healthcare

Access to resources Recommend Favorite